HRMY Stock: Price, Earnings History and SEC Filings
Harmony Biosciences Holdings, Inc. (HRMY) last traded at $38.76, up 0.44% on the latest session and down 1.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.28 against an analyst estimate of $0.97, a beat of 32.0%.
$38.76 +0.44%
1 month-1.27%
52-week high$43.49
52-week low$25.90
Volume871,473
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
HRMY earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $1.28 | $0.97 | +31.96% |
| Mar 2026 | May 7, 2026 | $0.55 | $0.76 | -27.63% |
| Dec 2025 | Feb 24, 2026 | $0.38 | $0.84 | -54.76% |
| Sep 2025 | Nov 4, 2025 | $0.87 | $0.92 | -5.43% |
HRMY beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for HRMY
SEC filing data is not available right now. You can search for HRMY on SEC EDGAR.
HRMY news
- PTC Therapeutics (PTCT) Q3 Earnings and Revenues Surpass EstimatesOct 29, 2026 · finance.yahoo.com
- Earnings Preview: BioAge Labs, Inc. (BIOA) Q3 Earnings Expected to DeclineOct 29, 2026 · finance.yahoo.com
- GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines SalesOct 28, 2026 · finance.yahoo.com
- Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings GrowthOct 28, 2026 · finance.yahoo.com
- Harmony Biosciences Grapples With A Leadership Transition That Spooked InvestorsOct 28, 2026 · finance.yahoo.com
- BHC Q3 Earnings Preview: Here's What You Should KnowOct 26, 2026 · finance.yahoo.com
- TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study DataOct 26, 2026 · finance.yahoo.com
- RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales FallOct 26, 2026 · finance.yahoo.com
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. (HRMY) is a US-listed public company on Nasdaq.